Table 1.
Summary of BC-related lncRNA expression datasets and corresponding clinical characteristics.
| Characteristic | GSE20685 (n=327) | GSE20711 (n=88) | GSE21653 (n=252) | GSE88770 (n=117) | GSE58812 (n=107) | |
|---|---|---|---|---|---|---|
| Age(years) | <=50 | 209 | 107 | 43 | ||
| >50 | 118 | 145 | 64 | |||
| Survival status | Living | 244 | 49 | 169 | 89 | 78 |
| Dead | 83 | 39 | 83 | 28 | 29 | |
| Metastasis stage | M0 (Living) | 244 (233) | 76 (73) | |||
| M1 (dead) | 83 (72) | 31 (26) | ||||
| Grade | 1 | 13 | 43 | 13 | ||
| 2 | 5 | 84 | 96 | |||
| 3 | 70 | 119 | 7 | |||
| ER status | Negative | 45 | 110 | 11 | 107 | |
| Positive | 42 | 140 | 106 | 0 | ||
| PR status | Negative | 123 | 37 | 107 | ||
| Positive | 126 | 79 | 0 | |||
| HER2 status | Negative | 62 | 206 | 108 | 107 | |
| Positive | 26 | 27 | 7 | 0 | ||
| Tumor stage | T1 | 101 | ||||
| T2 | 188 | |||||
| T3 | 26 | |||||
| T4 | 12 | |||||
| Lymph node stage | N0 | 137 | ||||
| N1 | 87 | |||||
| N2 | 63 | |||||
| N3 | 40 | |||||
| Subtype | Basal-like | 43 | 24 | 70 | ||
| Her2-enriched | 75 | 20 | 41 | |||
| Luminal A | 89 | 15 | 63 | |||
| Luminal B | 97 | 28 | 68 | |||
| Normal-like | 23 | 1 | 10 | |||
| Chemotherapy | No treatment | 59 | ||||
| CAF | 88 | |||||
| CMF | 61 | |||||
| Paclitaxel | 119 |